Why did a failed Novartis drug trial tank Amgen’s shares? And how is taxpayer money funding quantum-computing companies? Plus, will people pay $2,000 for a foldable iPhone? Host Imani Moise discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free <a href="https://www.wsj.com/newsletters/markets-am?mod=WSJ_WNPOD" target="_self" rel="noopener noreferrer">Markets A.M. newsletter</a>. Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover

WSJ What’s News

AI Chapters

AI Insights

Reviews